HF
GMAB icon

HRT Financial’s Genmab GMAB Stock Holding History

HRT Financial’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-49,232
Closed -$1.52M – 4136
2025
Q4 		$1.52M Sell
49,232
-17,683
-26% -$551K ﹤0.01% 1469
2025
Q3 		$2.05M Buy
+66,915
New +$1.63M 0.01% 1135
2025
Q1 		– Sell
-10,215
Closed -$213K – 2836
2024
Q4 		$213K Buy
+10,215
New +$224K ﹤0.01% 1902
2024
Q3 		– Sell
-10,351
Closed -$260K – 2687
2024
Q2 		$260K Buy
+10,351
New +$293K ﹤0.01% 1552
2023
Q4 		– Sell
-7,112
Closed -$250K – 2593
2023
Q3 		$250K Buy
+7,112
New +$271K ﹤0.01% 1740
2022
Q1 		– Sell
-59,893
Closed -$2.37M – 3371
2021
Q4 		$2.37M Buy
+59,893
New +$2.5M 0.01% 575

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

HRT Financial's GMAB Position: Q1 2026 in Review

HRT Financial sold out of Genmab (GMAB) in Q1 2026, closing a stake of 49,232 shares — an estimated $1.52M sold.

HRT Financial first reported a position in GMAB in Q4 2021 and held it in 6 quarters. The position peaked at $2.37M in Q4 2021. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • HRT Financial reported no remaining Genmab position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 49,232 Genmab shares in Q1 2026, an estimated $1.52M.
  • HRT Financial first reported a position in Genmab in Q4 2021 and held it in 6 quarters.
  • HRT Financial's Genmab position peaked at $2.37M in Q4 2021.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.